| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |